Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer

Citation
F. Tas et al., Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer, AM J CL ONC, 24(2), 2001, pp. 148-149
Citations number
8
Categorie Soggetti
Oncology
Journal title
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
ISSN journal
02773732 → ACNP
Volume
24
Issue
2
Year of publication
2001
Pages
148 - 149
Database
ISI
SICI code
0277-3732(200104)24:2<148:MOSC1M>2.0.ZU;2-P
Abstract
In 35 patients with recurrent gastric cancer who had undergone curative gas trectomy, serum carcinoembryonic antigen (CEA) and CA 19-9 (carbohydrate an tigen) rumor marker levels were investigated. At least one tumor marker was elevated in 24 (68.6%) patients. The levels of serum CA 19-9 and CEA marke rs were increased in 20 (57.1%,) and 12(34.3%) patients, respectively. This difference was not statistically significant. However, it may be important in terms of clinical practice.